DAPA-MI: Cardiometabolic Endpoints ‘Win’ With Dapagliflozin After Acute MI
(UPDATED) The trial needed to transfer out its tough number one endpoints for a win-ratio research: the outcome was once a “comfortable certain,” one observer stated. PHILADELPHIA, PA— Dapagliflozin given to acute
